Addressing Depression and Positive Parenting Techniques (ADAPT)
Launched by CENTRE FOR ADDICTION AND MENTAL HEALTH · Mar 4, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The ADAPT trial is studying a new treatment designed for parents who are dealing with depression while raising children with emotional and behavioral difficulties (EBD). This research recognizes that when parents are struggling with their own mental health, it can make it harder for them to support their children, leading to more challenges at home and in school. The goal of this trial is to see if a targeted approach to help these parents can improve both their well-being and their children's behavior.
To participate in the trial, parents need to be over 18 years old and have a child aged 6 to 10 who is experiencing significant emotional or behavioral issues. Additionally, parents must show signs of depression. Participants can expect to attend group sessions where they’ll receive support and strategies tailored to their needs. It's important to note that parents with certain severe mental health issues or specific diagnoses in their children, like Autism, won’t be able to join this study. The researchers hope to gather valuable insights that will improve future treatments for families facing these challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Parent is over the age of 18 years and has a child between the ages of 6 and 10;
- • Parent shows clinical elevations for Depression on the Patient Health Questionnaire (PHQ);
- • The child has clinically elevated Emotional Behavioural Difficulties (T-score of 65, Borderline range, 93rd percentile) on the Strength and Difficulties Questionnaire (Conduct Problem or Total Difficulties subscales);
- • The parent's has capacity to tolerate a group context.
- Exclusion Criteria:
- • Parent shows active suicidal ideation, substance use disorder, or psychosis;
- • Parent is not suitable for group treatment based on clinical interview;
- • Parent cannot communicate in English;
- • Child has a diagnosis of Autism Spectrum Disorder or Intellectual Disability (based on parent report).
About Centre For Addiction And Mental Health
The Centre for Addiction and Mental Health (CAMH) is Canada’s leading mental health and addiction teaching hospital, dedicated to advancing research, clinical care, and education in the field of mental health. With a commitment to improving the lives of individuals affected by mental illness and addiction, CAMH conducts innovative clinical trials aimed at developing and evaluating new treatment approaches. The institution fosters a collaborative environment that brings together researchers, clinicians, and community partners to translate scientific findings into effective interventions, ensuring the highest standards of care and support for patients. Through its robust research initiatives, CAMH strives to enhance understanding of mental health disorders and promote evidence-based practices in the treatment of addiction and mental health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
Toronto, Ontario, Canada
Patients applied
Trial Officials
Brendan F Andrade, Ph.D.
Principal Investigator
Centre for Addiction and Mental Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials